Kauffman Certifies Class In Generic Drug Lawsuit

A federal judge has certified a class action antitrust suit that accuses GlaxoSmithKline of using monopolistic tactics to boost its profits from Wellbutrin, a popular antidepressant, by delaying a generic version of the drug from coming to market. The suit was brought by direct purchasers who claim that GSK concocted a plan to keep Wellbu...

Continue to Kauffman Certifies Class In Generic Drug Lawsuit on Law.com - Business Law Practice Center.

The Daily Law gives you the latest news about law and legal issues from all over the world. Click below for more reading.
The Daily Law